Abstract:Background: Acute-on-chronic liver failure (ACLF) which has a high mortality, is frequent during the course of severe alcoholic hepatitis (SAH). Maddrey Discriminant Function (MDF), as a prognostic score special for alcoholic hepatitis, does not show a good prognostic value in ACLF associated with alcoholic liver disease (ALD). It is well-known that the serum levels of vitamin B12 (vitB12) and folic acid, as important substances in the methionine metabolism pathway, were altered in the patients of ALD and may impact on the outcomes of these patients. In this study, the relationship between vitB12 levels, erythrocyte parameters and severity of liver disease in patients with ALD was evaluated to improve the prediction of short-term prognosis in ALD-ACLF by combining with the valuable indexes. Methods: 139 ALD patients were included in the cross-sectional cohort and grouped according to different prognostic scores, the factors that affect the scores were collected and statistically analyzed. In addition, a retrospective cohort of 79 patients was investigated to reveal the correlation between vitB12 and Mean Corpuscular Volume (MCV) with the 28‐day mortality of ALD-ACLF. SPSS (20.0) and Medcalc (15.2.2) were used to perform statistical analyses. T-test, chi-square test or Fisher's as well as multivariate Logistic regression analysis were used. The ROC curve was plotted for relevant indicators, and the area under curve (AUC), cut-off value, sensitivity and specificity were calculated. Results: Patients with high scores in MDF, Model for End-stage Liver Disease (MELD) and Age-INR-Bilirubin-Creatine (AIBC), had higher vitB12 levels than those with low scores(1264.78±623.52 VS 634.04±426.57, P<0..001; 1498.47±640.48 VS 750.83±501.95, P<0.001; 1183.71±703.42 VS 813.24±553.32, P<0.05); MCV levels were higher in patients with high MDF scores (105.43±13.02 VS 99.24±13.52, P<0.05). The AUC of a new model of MDF combined with vitB12 and MCV for 28‐day mortality was 0.802, which was significantly higher than that of vitB12, MCV, and MDF scores.Conclusions: High levels of vitB12, MCV and the severity of ALD have a statistically significant correlation. MDF combined with vitB12 and MCV have been showed a good specificity to predict 28‐day mortality in ACLF-ALD and it may be a new promising prognostic model in ACLF-ALD.

A Promising Prognostic Model combining VitaminB12,Mean Corpuscular Volume and Maddrey Discriminant Function for Alcohol Acute-on-Chronic Liver Failure

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Evidence-based Incorporation of Key Parameters into MELD Score for Acute-on-chronic Liver Failure

A Modified Meld Model For Chinese Pre-Aclf And Aclf Patients And It Reveals Poor Prognosis In Pre-Aclf Patients

Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model

A Prognostic Model for Hepatitis B Acute-on-chronic Liver Failure Patients Treated Using a Plasma Exchange-Centered Liver Support System.

Prognostic Utility of Novel Biomarkers in Acute-on-chronic Liver Failure (ACLF) Associated with Hepatitis B: A Multicenter Prospective Study.

Establishing a Metabolomic Model for the Prognosis of Hepatitis B Virus-Induced Acute-on-chronic Liver Failure Treated with Different Liver Support Systems

Establishment of Prognostic Scoring Models for Different Etiologies of Acute Decompensation in Hospitalized Patients with Cirrhosis

The Model for End-stage Liver Disease 3.0 is Not Superior to the Model for End-stage Liver Disease-Na in Predicting Survival: A Retrospective Cohort Study.

A Novel Integrated Model for End-Stage Liver Disease Model Predicts Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-chronic Liver Failure Patients.

Predictive factors for mortality in patients with alcoholic cirrhosis

Prognostic Models for Acute Liver Failure.

Circulating Proteomic Panels For Diagnosis And Risk Stratification Of Acute-On-Chronic Liver Failure In Patients With Viral Hepatitis B

Decreased Vitamin D-binding Protein Level Portends Poor Outcome in Acute-on-chronic Liver Failure Caused by Hepatitis B Virus.

Values of different scores for diagnosing short-term prognosis of HBV-related acute-on-chronic liver failure

Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis.

Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.

Identification of Effective Diagnostic Biomarker and Immune Cell Infiltration Characteristics in Acute Liver Failure by Integrating Bioinformatics Analysis and Machine-Learning Strategies

Dynamic changes of MELD scores can predict the prognosis of HBV-related acute-on-chronic liver failure